B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OLR1

MOLECULAR TARGET

oxidized low density lipoprotein receptor 1

UniProt: P78380NCBI Gene: 49731 compounds

OLR1 (oxidized low density lipoprotein receptor 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OLR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1sesamol0.691

About OLR1 as a Drug Target

OLR1 (oxidized low density lipoprotein receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented OLR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OLR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.